Book Value per Share: Galapagos NV (GLPG)

Graphic logo of Galapagos NV (GLPG)

Galapagos NV (GLPG) relies on the implementation of artificial intelligence for molecule creation and the automation of manufacturing processes. A stable market status and a significant capital reserve, amounting to 57.47, allow the company to focus on CAR-T therapy and oncology while minimizing patent threats. This daily price chart for Galapagos NV (GLPG) complements data on diversified developments in cell therapy and immunology implemented through partnerships with pharma behemoths.

Galapagos N.V. (GLPG): Share Book Value from 07/04/2022 to 05/08/2026

glpg.com - analytical breakdowns and key metrics (GLPG)

- price and consensus price forecast:
Price Chart Galapagos Genomics|GLPG - Forecast Levels Chart
- market capitalization data:
Market Capitalization Galapagos NV|GLPG - Full Takeover Company Value
- book capitalization data:
Net Assets per Single Share Galapagos|GLPG - Net Asset Value|Market Capitalization to Book Value Ratio glpg.com|GLPG - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Galapagos NV|GLPG - Long-Term Debt to Capital|Short-Term Debt to Equity Galapagos|GLPG - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Galapagos NV
Fundamental company valuation:Galapagos Genomics - GLPG
Manufactured products of Galapagos

Investors are seeking objective metrics of intrinsic business value within the financial statements of Galapagos NV (GLPG). This indicator reflects the share of net assets attributable to a single security. By analyzing the trend of the book value per share, one can assess capital management efficiency and profit accumulation. For Galapagos NV (GLPG), this is evidenced by its ownership of R&D centers and CAR-T therapy facilities. Control over physical infrastructure directly capitalizes the company's balance sheet.

Competitors of Galapagos NV (GLPG)

Net Assets per Single Share Haleon Group|KVUE - Share Book Value|Book Value per Share VRNA (Verona Pharma plc)|MENS (jyongbio.com) - Book Value of One Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|anipharmaceuticals.com - Book Value per Share|Net Assets per Single Share MannKind (MNKD)|AMPH: Accounting Value of a Share|PCRX (Pacira) - Net Assets per Single Share|ARS Corp (SPRY) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|QNTM (Quantum BioPharma) - Book Value per Share|Book Value of One Share FibroGen Inc FGEN|Telomir Pharma - Book Value per Share|RANI: Book Value per Share|synergychc.com (SNYR) - Net Assets per Single Share|Rallybio (RLYB) - Net Assets per Single Share|LEXX (Lexaria Bioscience Corp) - Book Value per Share|Book Value per Share PULM|PTHL - Net Assets per Single Share|Share Book Value aptorumgroup.com (APM)|Book Value per Share LYRA (Lyra Therapeutics, Inc.)|Book Value per Share Impact BioMedical, Inc. IBO|Book Value per Share TNFA|YCBD: Book Value of One Share|Net Assets per Single Share PRFX|CYTO (Altamira Therapeutics Ltd.) - Net Asset Value per Share|LIPO: Net Assets per Single Share|Net Assets per Share optinose.com (OPTN)|Pieris Pharmaceuticals, Inc. (PIRS) - Accounting Value per Share|Accounting Value of a Share PROC (Procaps Group)|PTPI - Net Assets per Single Share|QLI - Equity per Share|SLRN - Accounting Value per Share|TFFP - Net Assets per Single Share